Relationship between sociodemographic, clinical, and laboratory characteristics and severity of COVID-19 in pediatric patients.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 23 10 2022
accepted: 01 03 2023
medline: 7 5 2024
pubmed: 7 5 2024
entrez: 7 5 2024
Statut: epublish

Résumé

COVID-19 affects children less seriously than adults; however, severe cases and deaths are documented. This study objective is to determine socio-demographic, clinical and laboratory indicators associated with severe pediatric COVID-19 and mortality at hospital entrance. A multicenter, retrospective, cross-sectional study was performed in 13 tertiary hospitals in Bolivia. Clinical records were collected retrospectively from patients less than 18 years of age and positive for SARS-CoV-2 infection. All variables were measured at hospital entrance; outcomes of interest were ICU admission and death. A score for disease severity was developed using a logistic regression model. 209 patients were included in the analysis. By the end of the study, 43 (20.6%) of children were admitted to the Intensive care unit (ICU), and 17 (8.1%) died. Five indicators were independently predictive of COVID-19 severity: age below 10 years OR: 3.3 (CI95%: 1.1-10.4), days with symptoms to medical care OR: 2.8 (CI95%: 1.2-6.5), breathing difficulty OR: 3.4 (CI95%: 1.4-8.2), vomiting OR: 3.3 (CI95%: 1.4-7.4), cutaneous lesions OR: 5.6 (CI95%: 1.9-16.6). Presence of three or more of these risk factors at hospital entrance predicted severe disease in COVID-19 positive children. Age, presence of underlying illness, male sex, breathing difficulty, and dehydration were predictive of death in COVID-19 children. Our study identifies several predictors of severe pediatric COVID-19 and death. Incorporating these predictors, we developed a tool that clinicians can use to identify children at high risk of severe COVID-19 in limited-resource settings.

Identifiants

pubmed: 38713667
doi: 10.1371/journal.pone.0283037
pii: PONE-D-22-29275
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0283037

Informations de copyright

Copyright: © 2024 Roca et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Cristian Roca (C)

Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.

Adriana Asturizaga (A)

Pediatric Pneumology Department, Caja de Salud de la Banca Privada, La Paz, Bolivia.

Nelson Villca (N)

Pediatric Pneumology Department, HODE Materno Infantil Hospital CNS, La Paz, Bolivia.

Ramiro Cabrera (R)

Pediatric Pneumology Department, Mario Ortiz Children's Hospital, Santa Cruz, Bolivia.

Raul Copana-Olmos (R)

Covid19 Intensive Care Unit, Manuel A. Villarroel Children's Hospital, Cochabamba, Bolivia.
Maternal Infant Department, Medicine Faculty San Simon University, Cochabamba, Bolivia.

Vladimir Aguilera-Avendano (V)

Pediatric Infectology Department, Ovidio Aliaga Uria Children's Hospital, La Paz, Bolivia.

Claudia Estrada-Villarroel (C)

Pediatric Infectology Department, Ovidio Aliaga Uria Children's Hospital, La Paz, Bolivia.

Mariel Andrea Forest-Yepez (MA)

Pediatric Intensive Care Unit, Materno Infantil Hospital CNS, La Paz, Bolivia.

Marcia Torrez-Santos (M)

Pediatric Department, North Hospital, El Alto, La Paz, Bolivia.

Adela Felipa Magne-Calle (AF)

Pediatric Department, North Hospital, El Alto, La Paz, Bolivia.

Maria Ofelia Foronda-Rios (MO)

Education and Research Department, Reidun Roine Materno Infantile Hospital, Riberalta, Bolivia.

Liz Malena Pena-Helguero (LM)

Education and Research Department, Reidun Roine Materno Infantile Hospital, Riberalta, Bolivia.

Monica Montalvo (M)

Pediatric Pneumology Department, Mario Ortiz Children's Hospital, Santa Cruz, Bolivia.

Delina Torrez (D)

Pediatric Intensive Care Department, Materno Infantil Hospital CNS, Santa Cruz, Bolivia.

Mirna Toco (M)

Department of Pediatrics, Hospital Cooperación Corea, Oruro, Bolivia.

Miguel Cespedes (M)

Pediatric Department, Bolivian Japanese Hospital Materno Infantil, Trinidad, Beni, Bolivia.

Ingrid Davalos (I)

Pediatric Intensive Care Department, North Hospital, El Alto, La Paz, Bolivia.

Natalie M Bowman (NM)

Division of Infectious Diseases, Department of Medicine, University of North Carolina, Chapel Hill, NC, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH